Lifespan Cancer Institute, Rhode Island Hospital — Providence, Rhode Island

Lifespan Cancer Institute, Rhode Island Hospital is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Lifespan Cancer Institute, Rhode Island Hospital has participated in 1 clinical trials.

Therapeutic areas: Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms.

Sponsors: Kazia Therapeutics Limited.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lifespan Cancer Institute, Rhode Island Hospital?

Lifespan Cancer Institute, Rhode Island Hospital has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lifespan Cancer Institute, Rhode Island Hospital conducted?

Lifespan Cancer Institute, Rhode Island Hospital has 1 clinical trials on record. Their work covers Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms.

Is Lifespan Cancer Institute, Rhode Island Hospital accredited by Crixeo Health?

Lifespan Cancer Institute, Rhode Island Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lifespan Cancer Institute, Rhode Island Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.